More about

Substance Use Disorders

News
April 18, 2024
2 min read
Save

Antipsychotics may prevent relapse in first-episode psychosis with cannabis use disorder

Antipsychotics may prevent relapse in first-episode psychosis with cannabis use disorder

Some antipsychotics other than olanzapine lowered the risk for hospitalization due to psychotic relapse among individuals with first-episode psychosis and co-occurring cannabis use disorder, according to a study in Schizophrenia Bulletin.

News
April 08, 2024
2 min read
Save

Partners, adult children of stroke survivors at higher risk for mental health conditions

Partners, adult children of stroke survivors at higher risk for mental health conditions

The risk for mental health conditions and self-harm or suicide was higher among partners and adult offspring of stroke survivors vs. the general population and family of myocardial infarction survivors, according to a study in Denmark.

News
March 14, 2024
2 min read
Save

Significant number of US teens report delta-8 THC use

Significant number of US teens  report delta-8 THC use

More than 1 in 10 high school seniors in the United States reported using delta-8 THC in the past year, according to survey results published in JAMA.

News
February 22, 2024
2 min read
Save

Suicide risk highest within 1 week of hospital discharge among people with depression

Suicide risk highest within 1 week of hospital discharge among people with depression

Patients hospitalized for depression appeared at greatest risk for suicide within the first week after discharge, according to a study conducted in Finland and published in JAMA Psychiatry.

News
January 16, 2024
2 min read
Save

Reducing drug use improves clinical outcomes in patients with stimulant use disorder

Reducing drug use improves clinical outcomes in patients with stimulant use disorder

Reduced drug use was linked to lower levels of craving, depression and other drug-related problems among individuals with stimulant use disorder, even if they did not achieve abstinence, according to a study published in Addiction.

News
January 16, 2024
2 min read
Save

Psilocybin reduces depression severity, improves symptoms in bipolar II disorder

Psilocybin reduces depression severity, improves symptoms in bipolar II disorder

A single, 25 mg dose of synthetic psilocybin along with psychotherapy was safe and effective among individuals with bipolar II disorder depression, supporting further study of psychedelics for these patients, according to research.

News
January 12, 2024
2 min read
Save

Q&A: US experiencing ‘very concerning’ rise in overdose deaths among adolescents

Q&A: US experiencing ‘very concerning’ rise in overdose deaths among adolescents

Overdose deaths among high school-aged adolescents in the United States more than doubled between 2019 and 2020, researchers reported this week in The New England Journal of Medicine found.

News
January 10, 2024
3 min read
Save

Alcohol, opioids most common causes of substance use-related heart disease deaths

Alcohol, opioids most common causes of substance use-related heart disease deaths

Substance use-related CVD deaths increased at an average of 4% per year from 1999 to 2019, with alcohol and opioids the most common contributors, despite an overall reduction in CVD mortality in the U.S. during the same period, data show.

News
December 26, 2023
2 min read
Save

New studies highlight changing trends in substance use, treatment among children

New studies highlight changing trends in substance use, treatment among children

Below is a list of stories involving substance use and children that were published by Healio in 2023.

News
December 20, 2023
1 min read
Save

NIH awards Delix $320K to advance neuroplastogen for substance use disorders

NIH awards Delix $320K to advance neuroplastogen for substance use disorders

Delix Therapeutics announced it has received a $320,000 grant from NIH’s National Institute on Drug Abuse to advance its novel, non-hallucinogenic neuroplastogen for treatment of substance use disorders, including opioid and stimulant use.

View more